Increased prevalence of Mycoplasma pneumoniae serological positivity in Chilean young children

J Carcey1, P Garcia2, O Padilla3

  • 1Division of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Abstract

Insights

Mycoplasma pneumoniae IgM seropositivity increased significantly in children and adolescents over a decade. School-aged children (5-18 years) saw the largest rise, with preschool-aged children (<5 years) showing the second-highest increase in infection rates.

Area of Science:

  • * Pediatric Infectious Diseases
  • * Respiratory Illness Epidemiology
  • * Microbiology and Immunology

Background:

  • * Mycoplasma pneumoniae is a common cause of respiratory infections in children and adolescents.
  • * Diagnosis is challenging due to a lack of specific symptoms.
  • * Understanding prevalence trends is crucial for public health interventions.

Purpose of the Study:

  • * To analyze the 10-year trend of Mycoplasma pneumoniae IgM seropositivity.
  • * To investigate age-specific prevalence variations, with a focus on preschool children.
  • * To identify demographic factors influencing seropositivity.

Main Methods:

  • * Retrospective analysis of 20,020 Mycoplasma pneumoniae IgM serological tests from 2004-2013.
  • * Data stratified by age groups: <5, 5-18, 19-50, 51-70, and >70 years.
  • * Evaluation of gender, month, and year of sample collection.

Main Results:

  • * Overall Mycoplasma pneumoniae seropositivity was 31.9%.
  • * Significant increases in seropositivity observed across all age groups over the decade.
  • * The 5-18 years group showed the highest increase (15.8% to 54%), followed by the <5 years group (8.6% to 30%).
  • * Women exhibited higher seropositivity, except in those over 50.

Conclusions:

  • * Mycoplasma pneumoniae seropositivity has markedly increased in pediatric populations over the last decade.
  • * Preschool-aged children (<5 years) experienced the second-highest rise in seropositivity.
  • * The findings highlight a growing burden of Mycoplasma pneumoniae infections in younger age groups.